Creatividad: Vogo/Alembic India

.

Corazon is a youngest division of Alembic’s cardio-metabolic team. 
Journey of Corazon embarked in the year 2014 with two focused brands Rosave and Vogo. Within a couple of years, the team marked its presence in market by increasing prescribers and prescriptions. During this journey, brands have been strengthened by the team through successful launching of new extensions to Rosave and Vogo. 
Trivogo has become an upcoming blockbuster brand for the team. With a strong cardiac portfolio comprising a range of Rosuvastatin products, from plain Rosuvastatin to combinations with Fenofibrate (Rosave F), Clopidogrel (Rosave C) and Cholecalciferol (Rosave D) and recently launched triple combination of Rosuvastatin, Clopidogrel and Aspirin (RosaveTrio), Alembic Corazon is now making inroads to the chronic market. Apart from statin, Corazon also has a strong anti-diabetic portfolio with the Vogo Range, comprising of plain Voglibose (Vogo), also in combination with metformin (Vogo-M), and recently launched triple combination (TriVogo). 
To serve Diabetes specialist better, we have recently introduced Alnex NT for Diabetic Neuropathy patients. With presence of all these wide treatment options Corazon has become 7th division in its represented market. With having Zeal & passion within, we are expecting to touch more such milestones in future.(Ver)